J.M. Hartwell’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$322K Buy
+12,000
New +$337K 0.06% 79
2019
Q2
Sell
-48,150
Closed -$1.67M 86
2019
Q1
$1.67M Buy
48,150
+13,900
+41% +$401K 0.3% 27
2018
Q4
$669K Buy
34,250
+6,100
+22% +$125K 0.14% 38
2018
Q3
$750K Sell
28,150
-2,900
-9% -$94.7K 0.13% 47
2018
Q2
$1.17M Buy
31,050
+825
+3% +$31.6K 0.21% 29
2018
Q1
$987K Buy
30,225
+1,100
+4% +$48.3K 0.19% 36
2017
Q4
$1.42M Sell
29,125
-6,325
-18% -$320K 0.27% 31
2017
Q3
$1.92M Buy
35,450
+21,200
+149% +$1.24M 0.37% 24
2017
Q2
$800K Buy
14,250
+4,000
+39% +$160K 0.17% 41
2017
Q1
$402K Buy
+10,250
New +$326K 0.09% 74

Other funds holding PTLA

J.M. Hartwell's PTLA Position: Q3 2019 in Review

J.M. Hartwell opened a new position in Portola Pharmaceuticals, Inc. (PTLA) in Q3 2019: 12,000 shares worth $322K. The stake represents 0.06% of the portfolio and ranks #79 among its holdings. This is a return to the name: J.M. Hartwell previously reported a position in PTLA as recently as Q1 2019.

J.M. Hartwell first reported a position in PTLA in Q1 2017 and has held it in 10 quarters since. The position peaked at $1.92M in Q3 2017. 212 funds tracked by Wall St. Rank hold PTLA as of Q3 2019.

  • J.M. Hartwell held 12,000 shares of Portola Pharmaceuticals, Inc. worth $322K as of Q3 2019.
  • Portola Pharmaceuticals, Inc. was a new J.M. Hartwell position in Q3 2019.
  • Portola Pharmaceuticals, Inc. made up 0.06% of J.M. Hartwell's portfolio in Q3 2019, its #79 holding.
  • J.M. Hartwell first reported a position in Portola Pharmaceuticals, Inc. in Q1 2017 and has held it in 10 quarters since.
  • J.M. Hartwell's Portola Pharmaceuticals, Inc. position peaked at $1.92M in Q3 2017.
  • 212 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2019.

Based on J.M. Hartwell's 13F filing for Q3 2019, filed 7 Oct 2019.